Promising FNAIT prevention drug study halted early
Disease control
Terminated
This study tested a drug called RLYB212 in pregnant women at high risk for a condition where the mother's immune system attacks the baby's platelets, causing dangerous bleeding. The goal was to see if the drug was safe and how it moved through the body. Only one participant was e…
Phase: PHASE2 • Sponsor: Rallybio • Aim: Disease control
Last updated May 26, 2026 10:34 UTC